Desmopressin for Improving Nocturnal Enuresis in Patients After Radical Cystectomy With Bladder Reconstruction
|ClinicalTrials.gov Identifier: NCT01582542|
Recruitment Status : Unknown
Verified April 2012 by Rabin Medical Center.
Recruitment status was: Active, not recruiting
First Posted : April 20, 2012
Last Update Posted : April 20, 2012
|Condition or disease||Intervention/treatment||Phase|
|Nocturnal Enuresis||Drug: Desmopressin||Phase 4|
We will prospectively assess the utilization of Desmopressin in improving nocturnal enuresis in patients after radical cystectomy with orthotopic bladder reconstruction.
Patients after radical cystectomy with neobladder reconstruction will be given Desmopressin 0.1 mg once a day for a duration of one month.
Before beginning treatment patients will be given the NNES-Q questionnaire to assess severity of nocturnal enuresis.
At the end of treatment, the same questionnaire will be given to all patients to assess if nocturnal enuresis improved.
Sodium levels will be tested before treatment, 2 weeks after beginning treatment and at the end of treatment.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||50 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Usage of Desmopressin fo Improving Nocturnal Enuresis in Patients After Radical Cystectomy With Orthotopic Bladder Reconstruction|
|Study Start Date :||April 2012|
|Estimated Primary Completion Date :||December 2013|
|Estimated Study Completion Date :||March 2014|
Patients after radical cystectomy with orthotopic bladder reconstruction that suffer from night time urinary incontinence will be enrolled in the study. They will be given for a period of one month after informed consent, Desmopressin At a dosage of 0.1 M"G per day. The rate of improvement of night time urinary incontinence will be measured.
- Rate of improvement in Nocturnal incontinence [ Time Frame: One month ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01582542
|Institute of Urology, Rabin Medical Cetner|
|Petah Tiqva, Petach Tiqva, Israel, 49100|
|Principal Investigator:||Ofer Yossepowitch, MD||Rabin Medical Center|